Lucid Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Lucid Diagnostics
LUCD Stock  USD 1.00  0.04  4.17%   
Lucid Diagnostics financial statements provide useful quarterly and yearly information to potential Lucid Diagnostics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Lucid Diagnostics financial statements helps investors assess Lucid Diagnostics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Lucid Diagnostics' valuation are summarized below:
Gross Profit
-3.2 M
Market Capitalization
55.4 M
Enterprise Value Revenue
26.2319
Revenue
4.2 M
Earnings Share
(1.12)
There are over one hundred nine available fundamental ratios for Lucid Diagnostics, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Lucid Diagnostics' last-minute performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. As of November 22, 2024, Market Cap is expected to decline to about 55.9 M. In addition to that, Enterprise Value is expected to decline to about 52.5 M

Lucid Diagnostics Total Revenue

2.55 Million

Check Lucid Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lucid Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 436.8 K, Tax Provision of 0.0 or Depreciation And Amortization of 2.7 M, as well as many indicators such as Price To Sales Ratio of 23.04, Dividend Yield of 0.0 or Days Sales Outstanding of 12.77. Lucid financial statements analysis is a perfect complement when working with Lucid Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Lucid Diagnostics Correlation against competitors.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.

Lucid Diagnostics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities30.9 M29.4 M6.8 M
Slightly volatile
Other Liabilities288.3 K324.4 K353.2 K
Slightly volatile
Accounts Payable1.3 M1.1 M821.1 K
Slightly volatile
Total Current Assets19.4 M22.1 M8.3 M
Slightly volatile
Common Stock28.6 K42 K17.7 K
Slightly volatile
Total Assets26.8 M27.3 M10.5 M
Slightly volatile
Other Current Liabilities9.1 M13.2 M6.7 M
Slightly volatile
Cash21 M18.9 M7.8 M
Slightly volatile
Non Current Assets Total3.6 M5.2 M1.7 M
Slightly volatile
Non Currrent Assets Other959.9 K1.1 M740.7 K
Slightly volatile
Other Assets0.951.0601.2 K
Slightly volatile
Cash And Short Term Investments21 M18.9 M7.8 M
Slightly volatile
Common Stock Shares Outstanding41.1 M41.8 M37.4 M
Slightly volatile
Short Term Investments1.6 M1.5 M458.9 K
Slightly volatile
Liabilities And Stockholders Equity26.8 M27.3 M10.5 M
Slightly volatile
Non Current Liabilities Total189.1 K199 K185.4 M
Pretty Stable
Other Current Assets1.8 M2.9 M815.1 K
Slightly volatile
Other Stockholder Equity19.7 B18.8 B2.6 B
Slightly volatile
Total Liabilities31.1 M29.6 M10.2 M
Slightly volatile
Capital Stock19.6 M18.7 M2.6 M
Slightly volatile
Net Receivables52.4 K45 K21 K
Slightly volatile
Property Plant Equipment1.4 M1.8 M1.1 M
Slightly volatile
Short and Long Term Debt Total9.5 M15.3 M3.4 M
Slightly volatile
Common Stock Total Equity32.8 K36.9 K40.2 K
Slightly volatile
Capital Surpluse96.9 M109 M118.7 M
Slightly volatile
Non Current Liabilities Other829.6 K933.3 K1 M
Slightly volatile
Short Term Debt8.8 M15.1 M2.4 M
Slightly volatile
Intangible Assets1.9 M1.4 M3.2 M
Slightly volatile
Short and Long Term Debt11.2 M12.6 M13.7 M
Slightly volatile

Lucid Diagnostics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.7 M2.5 M4 M
Slightly volatile
Selling General Administrative13.1 M19.3 M5.4 M
Slightly volatile
Other Operating Expenses32.6 M50.9 M14.7 M
Slightly volatile
Research Development8.1 M7.3 M5.1 M
Slightly volatile
Total Operating Expenses29.8 M42.4 M13.7 M
Slightly volatile
Selling And Marketing Expenses10.8 M16.4 M4.2 M
Slightly volatile
Interest Income281.6 K424 K123.3 K
Slightly volatile

Lucid Diagnostics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings9.3 M8.9 M2.9 M
Slightly volatile
Depreciation2.6 M2.5 M473.8 K
Slightly volatile
Capital Expenditures209.9 K221 K778.9 K
Slightly volatile
Change To Operating Activities11.1 M10.5 M2.6 M
Slightly volatile
Total Cash From Financing Activities20.6 M29.5 M9 M
Slightly volatile
End Period Cash Flow17.5 M18.9 M7.5 M
Slightly volatile
Change To Netincome16.7 M15.9 M4 M
Slightly volatile
Stock Based Compensation7 M6.8 M2.7 M
Slightly volatile
Change In Working Capital4.4 M5.7 M2.7 M
Slightly volatile
Begin Period Cash Flow16.8 M22.5 M6.2 M
Slightly volatile
Sale Purchase Of Stock363 M551 M155.4 M
Slightly volatile
Change Receivables146.4 K164.7 K179.3 K
Slightly volatile
Cash Flows Other Operating2.4 M2.7 M2.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio23.0424.2488312
Slightly volatile
Days Sales Outstanding12.776.764815.5667
Slightly volatile
Average Payables1.1 M1.3 M1.4 M
Slightly volatile
Stock Based Compensation To Revenue2.672.809718.3746
Pretty Stable
Capex To Depreciation0.0840.0884172
Slightly volatile
EV To Sales21.6122.7492222
Slightly volatile
Inventory Turnover17.1330.49646.295
Slightly volatile
Days Of Inventory On Hand11.3711.9686248
Slightly volatile
Payables Turnover7.777.39791.5534
Slightly volatile
Sales General And Administrative To Revenue7.537.9325.6638
Very volatile
Average Inventory432.1 K597 K462.8 K
Slightly volatile
Research And Ddevelopement To Revenue2.842.986817.2896
Slightly volatile
Capex To Revenue0.08650.0911.5516
Slightly volatile
Cash Per Share0.360.45250.2038
Slightly volatile
Days Payables Outstanding46.8749.3383757
Slightly volatile
Income Quality0.420.62310.2882
Slightly volatile
Intangibles To Total Assets0.0870.05220.1011
Slightly volatile
Current Ratio0.710.75121.207
Slightly volatile
Receivables Turnover56.6553.955610.8521
Slightly volatile
Graham Number1.81.25321.0933
Slightly volatile
Capex Per Share0.0050.00530.0221
Slightly volatile
Revenue Per Share0.06110.05810.0201
Slightly volatile
Interest Debt Per Share0.360.3440.062
Slightly volatile
Debt To Assets0.410.460.5013
Slightly volatile
Operating Cycle17.818.7335367
Slightly volatile
Days Of Payables Outstanding46.8749.3383757
Slightly volatile
Ebt Per Ebit0.830.980.9979
Pretty Stable
Total Debt To Capitalization0.961.081.1747
Slightly volatile
Quick Ratio0.70.74181.1936
Slightly volatile
Net Income Per E B T0.820.921.003
Slightly volatile
Cash Ratio0.610.64311.1131
Slightly volatile
Days Of Inventory Outstanding11.3711.9686248
Slightly volatile
Days Of Sales Outstanding12.776.764815.5667
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.00671.0502
Pretty Stable
Fixed Asset Turnover0.970.91930.5449
Slightly volatile
Debt Ratio0.410.460.5013
Slightly volatile
Price Sales Ratio23.0424.2488312
Slightly volatile
Asset Turnover0.09350.0890.0197
Slightly volatile

Lucid Diagnostics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap55.9 M58.9 M342.5 M
Slightly volatile
Enterprise Value52.5 M55.2 M337 M
Slightly volatile

Lucid Fundamental Market Drivers

Cash And Short Term Investments18.9 M

Lucid Upcoming Events

12th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Lucid Diagnostics Financial Statements

Lucid Diagnostics stakeholders use historical fundamental indicators, such as Lucid Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Lucid Diagnostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Lucid Diagnostics' assets and liabilities are reflected in the revenues and expenses on Lucid Diagnostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Lucid Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.4 M2.5 M
Cost Of Revenue8.5 M8.9 M
Stock Based Compensation To Revenue 2.81  2.67 
Sales General And Administrative To Revenue 7.93  7.53 
Research And Ddevelopement To Revenue 2.99  2.84 
Capex To Revenue 0.09  0.09 
Revenue Per Share 0.06  0.06 
Ebit Per Revenue(19.97)(20.97)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:
How To Invest In Lucid
Details
Is Lucid Stock a good investment?
Details
What is Lucid Diagnostics' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Lucid Diagnostics Correlation against competitors.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
0.09
Quarterly Revenue Growth
0.497
Return On Assets
(1.01)
Return On Equity
(10.08)
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY